Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its structure allows for selective modification, making it valuable in creating active ingredients for targeted cancer therapies. Commonly employed in medicinal chemistry for constructing pyrrolopyrimidine-based scaffolds, which exhibit biological activity against various disease targets. Also utilized in research settings to develop novel drug candidates due to its reactivity and functional group compatibility in cross-coupling reactions.